Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?Ekim Ekinci, Meghana V. Trivedi, Susan Abughosh et al.|Journal of Cancer Survivorship|2018Cited by 72
Neratinib in HER2-Positive Breast Cancer PatientsRutugandha Paranjpe, Meghana V. Trivedi, Dima Basatneh et al.|Annals of Pharmacotherapy|2019Cited by 30
Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer PatientsKaitlin Rascon, Ekim Ekinci, Meghana V. Trivedi et al.|Annals of Pharmacotherapy|2018Cited by 22